摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Ethyl--sulfon | 118757-16-7

中文名称
——
中文别名
——
英文名称
Ethyl--sulfon
英文别名
ethyl-[1]naphthyl sulfone;Aethyl-[1]naphthyl-sulfon;Aethyl-α-naphthyl-sulfon;1-Ethylsulfonylnaphthalene
Ethyl-<naphthyl-(1)>-sulfon化学式
CAS
118757-16-7
化学式
C12H12O2S
mdl
——
分子量
220.292
InChiKey
DSPQDLNLBJYHKR-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    418.4±18.0 °C(Predicted)
  • 密度:
    1.211±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.7
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    42.5
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    参考文献:
    名称:
    Hauptmann et al., Justus Liebigs Annalen der Chemie, 1952, vol. 576, p. 45,56
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
    申请人:Lynch K. John
    公开号:US20050209274A1
    公开(公告)日:2005-09-22
    The present invention is directed to compounds of formula (I), which antagonize of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    本发明涉及式(I)的化合物,通过对抗黑素浓集激素(MCH)的作用,通过对抗黑素浓集激素受体,有助于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质稳态、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫、神经退行性疾病和精神障碍。
  • RECORDING MATERIAL PRODUCED USING NON-PHENOL COMPOUND
    申请人:NIPPON SODA CO., LTD.
    公开号:US20150284321A1
    公开(公告)日:2015-10-08
    An object of the present invention is to provide a recording material or a recording sheet using, as a color-developing agent, a non-phenol compound that is a safe compound in no danger of corresponding to an endocrine disruptor and is good in color developing performance. The non-phenol compound used in the present invention is at least one selected from the group consisting of compounds represented by the following formulas (I) to (III).
    本发明的目的是提供一种使用非酚类化合物作为显色剂的记录材料或记录纸,该非酚类化合物是一种安全化合物,不会对应到内分泌干扰物,并且在显色性能方面表现良好。本发明中使用的非酚类化合物至少选自以下化合物所代表的化合物组,其化学式为(I)至(III)。
  • USE OF SUBSTITUTE OXO TETRAHYDROQUINOLINE SULFONAMIDES OR SALTS THEREOF FOR RAISING STRESS TOLERANCE OF PLANTS
    申请人:BAYER CROPSCIENCE AKTIENGESELLSCHAFT
    公开号:US20170027172A1
    公开(公告)日:2017-02-02
    The invention relates to the use of substituted oxotetrahydroquinolinylsulfonamides or salts thereof where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress, and/or for increasing plant yield.
    该发明涉及使用取代的氧代四氢喹啉磺酰胺或其盐,其中一般式(I)中的基团对应于描述中给定的定义,用于增强植物对非生物胁迫的耐受性,和/或增加植物产量。
  • PIPERIZINYL MACROCYCLIC HEPATITIS C SERINE PROTEASE INHIBITORS
    申请人:Sun Ying
    公开号:US20080286233A1
    公开(公告)日:2008-11-20
    The present invention relates to compounds of Formula I, or a pharmaceutically acceptable salt, ester, or prodrug, thereof: which inhibit serine protease activity, particularly the activity of hepatitis C virus (HCV) NS3-NS4A protease. Consequently, the compounds of the present invention interfere with the life cycle of the hepatitis C virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HCV infection. The invention also relates to methods of treating an HCV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.
    本发明涉及式I的化合物,或其药学上可接受的盐、酯或前药:这些化合物抑制丝氨酸蛋白酶活性,特别是乙型肝炎病毒(HCV)NS3-NS4A蛋白酶的活性。因此,本发明的化合物干扰了乙型肝炎病毒的生命周期,也可用作抗病毒剂。本发明还涉及包含上述化合物的药物组合物,用于治疗患有HCV感染的受试者。本发明还涉及通过给予含有本发明化合物的药物组合物来治疗受试者的HCV感染的方法。
  • Antagonists of melanin concentrating hormone effects on the melanin concetrating hormone receptor
    申请人:——
    公开号:US20030229119A1
    公开(公告)日:2003-12-11
    The present invention relates to the antagonism of the effects of melanin-concentrating hormone (MCH) through the melanin concentrating hormone receptor which is useful for the prevention or treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizures, neurodegeneration and psychiatric disorders.
    本发明涉及通过黑素浓缩激素受体对黑素浓缩激素(MCH)效果的拮抗,对于预防或治疗进食障碍、体重增加、肥胖、生殖和性行为异常、甲状腺激素分泌、利尿和水/电解质平衡、感觉处理、记忆、睡眠、觉醒、焦虑、抑郁、癫痫发作、神经退行性疾病和精神疾病是有用的。
查看更多